MEGAN PIEPER: Open Payments
NPI 1740733963 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$354 in 15 payments from 9 companies in 2025. Trend: 2023 $358 · 2024 $100 · 2025 $354
Food & beverage: $354
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 4 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| Novo Nordisk Inc | 1 | $27 |
| Hologic Sales and Service, LLC | 1 | $25 |
| ViiV Healthcare Company | 1 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $21 |
| PFIZER INC. | 1 | $20 |
Products named: TRINTELLIX, Wegovy, APTIMA, APRETUDE, Cologuard Collection Kit, FREESTYLE LIBRE 3, PREVNAR 20.
Industry payments across TX — which companies pay providers there.
